Literature DB >> 18247325

Merging molecular imaging and RNA interference: early experience in live animals.

Alexei A Bogdanov1.   

Abstract

The rapid development of non-invasive imaging techniques and imaging reporters coincided with the enthusiastic response that the introduction of RNA interference (RNAi) techniques created in the research community. Imaging in experimental animals provides quantitative or semi-quantitative information regarding the biodistribution of small interfering RNAs and the levels of gene interference (i.e., knockdown of the target mRNA) in living animals. In this review we give a brief summary of the first imaging findings that have potential for accelerating the development and testing of new approaches that explore RNAi as a method for achieving loss-of-function effects in vivo and as a promising therapeutic tool. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247325      PMCID: PMC4836383          DOI: 10.1002/jcb.21689

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  57 in total

1.  A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.

Authors:  Kum-Joo Shin; Estelle A Wall; Joelle R Zavzavadjian; Leah A Santat; Jamie Liu; Jong-Ik Hwang; Robert Rebres; Tamara Roach; William Seaman; Melvin I Simon; Iain D C Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 3.  The development of in vivo imaging systems to study gene expression.

Authors:  A Bogdanov; R Weissleder
Journal:  Trends Biotechnol       Date:  1998-01       Impact factor: 19.536

4.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

5.  Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.

Authors:  Kristen Bisanz; Jie Yu; Magnus Edlund; Bill Spohn; Mien-Chie Hung; Leland W K Chung; Chia-Ling Hsieh
Journal:  Mol Ther       Date:  2005-10       Impact factor: 11.454

6.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

7.  Single-nucleotide-specific siRNA targeting in a dominant-negative skin model.

Authors:  Robyn P Hickerson; Frances J D Smith; Robert E Reeves; Christopher H Contag; Devin Leake; Sancy A Leachman; Leonard M Milstone; W H Irwin McLean; Roger L Kaspar
Journal:  J Invest Dermatol       Date:  2007-10-11       Impact factor: 8.551

8.  Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.

Authors:  Olaf R Mook; Frank Baas; Marit B de Wissel; Kees Fluiter
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261

9.  Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model.

Authors:  Qian Wang; Heini Ilves; Pauline Chu; Christopher H Contag; Devin Leake; Brian H Johnston; Roger L Kaspar
Journal:  J Invest Dermatol       Date:  2007-05-24       Impact factor: 8.551

10.  In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

Authors:  M Golzio; L Mazzolini; A Ledoux; A Paganin; M Izard; L Hellaudais; A Bieth; M J Pillaire; C Cazaux; J S Hoffmann; B Couderc; J Teissié
Journal:  Gene Ther       Date:  2007-03-08       Impact factor: 5.250

View more
  5 in total

Review 1.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

Review 2.  In vivo imaging of RNA interference.

Authors:  Hao Hong; Yin Zhang; Weibo Cai
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

3.  Imaging CXCR4 Expression with (99m)Tc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts.

Authors:  Peng Fu; Lin Tian; Xueliang Cao; Li Li; Peng Xu; Changjiu Zhao
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

4.  Fluorocarbons Enhance Intracellular Delivery of Short STAT3-sensors and Enable Specific Imaging.

Authors:  Valeriy Metelev; Surong Zhang; Shaokuan Zheng; Anand T N Kumar; Alexei Bogdanov
Journal:  Theranostics       Date:  2017-08-03       Impact factor: 11.556

Review 5.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.